- £196.16bn
- £215.32bn
- $54.07bn
- 85
- 17
- 83
- 70
REG - AstraZeneca PLC - Total Voting Rights <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AstraZeneca Pipeline <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - Second Quarter & Half Year Results 2014 <Origin Href="QuoteRef">AZN.L</Origin> - Part 3
AnnouncementREG - AstraZeneca PLC - Second Quarter & Half Year Results 2014 <Origin Href="QuoteRef">AZN.L</Origin> - Part 2
AnnouncementREG - AstraZeneca PLC - Second Quarter & Half Year Results 2014 <Origin Href="QuoteRef">AZN.L</Origin> - Part 1
AnnouncementREG - DDD Group PLC - Issue of Convertible Unsecured Loan Notes <Origin Href="QuoteRef">AZN.L</Origin> <Origin Href="QuoteRef">DDDL.L</Origin>
AnnouncementREG - AstraZeneca PLC - Notice of Results <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - STRATEGIC RESPIRATORY TRANSACTION WITH ALMIRALL <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - FDA AdCom recommends no CV trial for PAMORA class <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - ASTRAZENECA IN-LICENSES SYNAIRGEN'S SNG001 <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementREG - AstraZeneca PLC - AZ TO PRESENT NEW DATA AT ADA <Origin Href="QuoteRef">AZN.L</Origin>
AnnouncementResponse to US FDA CRL for Br
AnnouncementTransaction in Own Shares
AnnouncementAstraZeneca PLC - Seroquel XR
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
AnnouncementAstraZeneca PLC - Transaction in Own Shares
Announcement